hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Pfizer to pay $430 million for false drug marketing

Author: Lisa Richwine, Reuters, Published on: 13 May 2004

Pfizer has agreed to pay $430 million (245 million pounds) and plead guilty to criminal charges for illegally marketing an epilepsy drug for unapproved uses such as migraines and pain, U.S. prosecutors say...The company's Warner-Lambert division promoted the drug, Neurontin, for uses it had no scientific evidence to support...[also refers to TAP Pharmaceuticals (joint venture Abbott Laboratories & Takeda Chemical Industries)]

Read the full post here

Related companies: Abbott Laboratories Pfizer Takeda Pharmaceutical TAP Pharmaceuticals (joint venture Abbott Laboratories & Takeda Pharmaceutical) Warner-Lambert (part of Pfizer)